THE CYSTEINE PROTEASE CATHEPSIN B IS A KEY DRUG TARGET AND CYSTEINE PROTEASE INHIBITORS ARE POTENTIAL THERAPEUTICS FOR TBI

被引：0
|
作者：
Hook, G. R. [1 ]
Yu, J. [2 ,3 ]
Sipes, N. [1 ]
Pierschbacher, M. D. [1 ]
Hook, V [4 ]
Kindy, M. S. [2 ,3 ]
机构：
[1] Amer Life Sci Pharmaceut, La Jolla, CA USA
[2] Med Univ S Carolina, Charleston, SC USA
[3] Appl Neurotechnol Inc, Charleston, SC USA
[4] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
JOURNAL OF NEUROTRAUMA | 2014年 / 31卷 / 12期
关键词：
cathepsin B; drug; target; TBI;
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
C2-34
引用
收藏
页码：A88 / A88
页数：1
相关论文
共 50 条
  • [21] Synthesis of quinoline derivatives as potential cysteine protease inhibitors
    Andrade, Marina M. S.
    Martins, Luan C.
    Marques, Gabriel V. L.
    Silva, Carla A.
    Faria, Gilson
    Caldas, Sergio
    dos Santos, Janete S. C.
    Leclercq, Sophie Y.
    Maltarollo, Vinicius G.
    Ferreira, Rafaela S.
    Oliveira, Renata B.
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (07) : 571 - 581
  • [22] Advances in Cysteine Protease B Inhibitors for Leishmaniasis Treatment
    Gini, Ana Luisa Rodriguez
    Joao, Emilio Emilio
    Lopes, Juliana Romano
    Da Cunha, Pamela Souza Tada
    Velasquez, Angela Maria Arenas
    Graminha, Marcia Aparecida Silva
    dos Santos, Jean Leandro
    Scarim, Caue Benito
    CURRENT DRUG TARGETS, 2025, 26 (02) : 88 - 108
  • [23] Isothiazolones; thiol-reactive inhibitors of cysteine protease cathepsin B and histone acetyltransferase PCAF
    Wisastra, Rosalina
    Ghizzoni, Massimo
    Maarsingh, Harm
    Minnaard, Adriaan J.
    Haisma, Hidde J.
    Dekker, Frank J.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2011, 9 (06) : 1817 - 1822
  • [24] Cysteine protease inhibitors as chemotherapy: Lessons from a parasite target
    Selzer, PM
    Pingel, S
    Hsieh, I
    Ugele, B
    Chan, VJ
    Engel, JC
    Bogyo, M
    Russell, DG
    Sakanari, JA
    McKerrow, JH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) : 11015 - 11022
  • [25] Characterisation of cathepsin B-like cysteine protease of Lepeophtheirus salmonis
    Cunningham, Eleanor
    McCarthy, Elaine
    Copley, Lorraine
    Jackson, Dave
    Johnson, David
    Dalton, John P.
    Mulcahy, Grace
    AQUACULTURE, 2010, 310 (1-2) : 38 - 42
  • [26] Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells
    Quilles Junior, Jose C.
    Rocho Carlos, Fernanda dos Reis
    Montanari, A.
    Leitao, Andrei
    Mignone, Viviane W.
    Arruda, Maria Augusta
    Turyanska, Lyudmila
    Bradshaw, Tracey D.
    RSC ADVANCES, 2019, 9 (63) : 36699 - 36706
  • [27] Intracellular targeting of cysteine protease inhibitors
    Mason, RW
    Xing, RY
    FASEB JOURNAL, 1997, 11 (09): : A929 - A929
  • [28] Library of serine and cysteine protease inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (03) : 123 - 124
  • [29] Attenuation of cathepsin K processing and turnover in osteoclasts by cysteine protease inhibitors.
    Rieman, DJ
    James, IE
    Dodds, R
    McClung, HA
    Lee-Rykaczewski, J
    Marquis, R
    Yamashita, D
    Lark, M
    Veber, D
    Drake, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S357 - S357
  • [30] Rational design of thioamide peptides as selective inhibitors of cysteine protease cathepsin L
    Phan, Hoang Anh T.
    Giannakoulias, Sam G.
    Barrett, Taylor M.
    Liu, Chunxiao
    Petersson, E. James
    CHEMICAL SCIENCE, 2021, 12 (32) : 10825 - 10835
12345